Russia approves first coronavirus prescription drug for sale in pharmacies

Russia approves first coronavirus prescription drug for sale in pharmacies

Russia has approved R-Pharm’s Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies in the country as soon as next week, the company said.

Coronavir’s approval as a prescription drug follows the green light for another Russian COVID-19 drug, Avifavir, in May.

R-Pharm said it received approval for Coronavir after Phase III clinical trials involving 168 patients with COVID-19.

It was first approved for in-hospital use in July.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

multimedia

news